Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT04657822 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 130 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 27, 2025 (Oct 27, 2025) |
As of March 2, 2026: Clinical trial NCT04657822 is currently recruiting participants. This clinical trial study for sickle cell disease is actively seeking new participants at 7 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04657822 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04657822 was last updated Oct 27, 2025 (October 27, 2025). HelloStudys verifies this status automatically.